How do you stand out in rare neurological research? At Worldwide, we turn challenges into solutions, ensuring your trial’s success in both high- and low-competition environments by prioritizing patient voices and leveraging expert strategies. Find out how we do it in our blog: https://ow.ly/F6bs50St3xx
Worldwide Clinical Trials’ Post
More Relevant Posts
-
What fantastic news in the fight against obesity! Looking forward to making continuous advancements in metabolic research for conditions like NAFLD and MASLD.
Breaking News: The Treat and Reduce Obesity Act has passed the Ways and Means Committee! We extend our thanks to Chairman Congressman Jason Smith and all committee members who voted in favor. This legislation is a crucial first step in our ongoing fight against obesity, a major contributor to nonalcoholic fatty liver disease (NAFLD), now called metabolic dysfunction-associated steatotic liver disease (MASLD). This milestone is not just a win in the battle against obesity but also a beacon of hope for millions struggling with associated health conditions. Join us as we continue to push for meaningful change: https://alf.social/sys
-
-
Interested in the latest methods and solutions for running your oncology clinical trial? Make sure to check out james eamma’s presentation at Clinical Trials in Oncology East Coast next week, and stop by Booth 21 to speak to him about any questions you may have! https://ow.ly/k21H50Su0Jk
-
-
At Worldwide, we're dedicated to enhancing your drug development journey through our people, processes, and technologies in our bioanalytical lab and clinical pharmacology unit. This commitment is embodied in our continuous improvement initiative — WorldwideEdge. Learn more: https://ow.ly/rJ9f50SsTnS
-
-
Are you ready to make an impact in rare disease research? At Worldwide, we provide bespoke, patient-centered solutions for your rare disease program, from advocacy engagement to clinical assessment and technology. Discover more about our distinct rare disease methodology and expertise today: https://ow.ly/Jhmq50SsJkL
Make Your Move into Rare Disease Research Confidently
worldwide.com
-
Radiopharmaceuticals are continuously evolving – work with a partner who specializes in this dynamic field. Discover Worldwide’s experience in radiopharmaceutical development from oncology to rare disease in our fact sheet: https://ow.ly/XYsQ50Sra23
Radiopharmaceutical Development at Worldwide Clinical Trials
worldwide.com
-
In honor of Alzheimer's and Brain Awareness Month, Tom Babic reflects on the significant milestone passed in treating those affected by Alzheimer's disease: “While not a cure, lecanemab is the first FDA-approved drug in over 20 years to show an unequivocal positive effect in subjects with Alzheimer’s disease (AD). Made possible by the collective advancement in understanding of AD’s biology, diagnostics, and treatments, lecanemab presents an opportunity for patients at the Roskamp Institute and across the US to slow the progression of their devastating disease. It’s always rewarding to hear the direct impact of Worldwide’s work on patients and their families.” https://ow.ly/Ov7V50Sr9CU
Florida clinic plans to treat 10,000 Alzheimer’s patients a year. Look at what’s coming
miamiherald.com
-
Did you know the importance of effective project managers to your clinical trial? Find out the difference it makes and hear what other clients have to say about our project management expertise: https://ow.ly/rIPU50Sr6Ue
-
-
How do you know which Bayesian optimal interval (BOIN) design is right for your study? Fortunately, we’ve created the guide to help you discover which BOIN is suitable for your oncology study. Check it out today: https://ow.ly/r25G50SqskF
Select the Right Bayesian Optimized Interval (BOIN) Design for Your Oncology Study
worldwide.com
-
What a heartwarming message from Joy Clark and Derek Ansel, MS, CGC on how Worldwide champions patient advocacy and community engagement! We're proud of our team members who work with passion and purpose both inside and outside of Worldwide. Check out how GozAround Inc. helps our global team connect and engage in personally meaningful initiatives:
We are so proud to showcase our client Worldwide Clinical Trials and their incredible commitment to patient advocacy and community support. In this video, Joy Clark (Chief People Officer) and Derek Ansel, MS, CGC (Executive Director, Rare Diseases) share how their organization fosters a culture of passion and purpose leading to improved employee engagement and retention. See how GozAround helps their global team connect and engage in personally meaningful initiatives. Learn more at https://lnkd.in/gEyKbKZV! #CommunityImpact #EmployeeEngagement #CHRO #CSR #GozAround
Chief Executive Officer at USA and International Research Inc.
2dStanding out in rare neurological research is crucial, and Worldwide is leading the charge by prioritizing patient voices and expert strategies.